Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Motor Activity × Dermatologic × Clear all

Status

Sponsor Class

Study Type

Interventional 10 Observational 1

Sponsor

Cancer Type

Breast 27 Gastrointestinal 14 Other hematologic neoplasm 10 Thoracic 9 Lymphoid 8 Other 7 Genitourinary 6 Endocrine 2 Sarcoma 1 Gynecologic 1 Dermatologic 1 CNS 1

Conditions

Melanoma 393 Skin Neoplasms 118 Carcinoma, Basal Cell 75 Breast Neoplasms 62 Neoplasms 52 Lymphoma, T-Cell, Cutaneous 51 Lung Neoplasms 45 Carcinoma, Squamous Cell 34 Uveal Melanoma 33 Carcinoma, Non-Small-Cell Lung 33 Mycosis Fungoides 31 Keratosis, Actinic 31 Sezary Syndrome 30 Sarcoma 28 Prostatic Neoplasms 26 Urinary Bladder Neoplasms 25 Lymphoma, Non-Hodgkin 25 Lymphoma 25 Leukemia, Lymphocytic, Chronic, B-Cell 24 Carcinoma, Renal Cell 24 Pancreatic Neoplasms 23 Ovarian Neoplasms 23 Head and Neck Neoplasms 22 Colorectal Neoplasms 22 Colonic Neoplasms 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Multiple Myeloma 20 Lymphoma, B-Cell, Marginal Zone 20 Hodgkin Disease 20 Lymphoma, Mantle-Cell 19

Interventions

pembrolizumab 1 Nivolumab 1 Ipilimumab 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06627595 2024-11-15

APiTOXMM

University Hospital, Montpellier

Melanoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡